Only 0.01% of drug candidates entering clinical trials reach the market. With Charles River supporting >80% of drugs approved by the FDA over the last five years, improve your odds, leverage our experience, and expedite your time to market. Learn more about your global manufacturing and testing services at www.criver.com/biologics-solutions.